Stock NYMXF NYMOX PHARMACEUTICAL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Nymox Pharmaceutical Corporation

Equities

NYMXF

BSP733981026

Delayed OTC Markets
Other stock markets
 14:30:00 20/05/2024 BST 		5-day change 1st Jan Change
0.2099 USD -3.24% Intraday chart for Nymox Pharmaceutical Corporation -32.49% -64.42%
2023 Nymox Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 Nymox Pharmaceutical Corporation Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
NYMOX PHARMACEUTICAL CORPORATION Stock Nymox Pharmaceutical Corporation
 20.25M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 50.93B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 42.12B
LONZA GROUP AG Stock Lonza Group AG
 42.05B
CELLTRION, INC. Stock Celltrion, Inc.
 29.18B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.02B
  1. Stock Market
  2. Equities
  3. NYMXF Stock
  4. Charts Nymox Pharmaceutical Corporation
  5. Sector Chart